Importantly, phosphatases are gaining recognition as potential targets for chemotherapeutic intervention [80], and have been estimated to represent 4% of the druggable human genome; in particular, PTPs appear an important new target for cancer therapy, notably for melanoma (reviewed in [81]). This evidence concerns the gene PTS and melanoma.